BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16479615)

  • 1. Novel apoptosis assay to analyze immunosuppression.
    Boldt A; Barten MJ; Weiss C; Sagner A; Mohr FW; Gummert JF
    Cytometry A; 2006 Mar; 69(3):158-60. PubMed ID: 16479615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo.
    Boldt A; Barten MJ; Sagner A; Mohr FW; Adams V; Dhein S; Gummert JF
    Transplantation; 2006 Aug; 82(3):422-7. PubMed ID: 16906043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
    Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
    Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF
    J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of T-cell apoptosis by immunosuppressive agents.
    Takahashi K; Reynolds M; Ogawa N; Longo DL; Burdick J
    Clin Transplant; 2004; 18 Suppl 12():72-5. PubMed ID: 15217412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.
    Barten MJ; Shipkova M; Bartsch P; Dhein S; Streit F; Tarnok A; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Ther Drug Monit; 2005 Apr; 27(2):123-31. PubMed ID: 15795640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.
    Buron F; Perrin H; Malcus C; Héquet O; Thaunat O; Kholopp-Sarda MN; Moulin FT; Morelon E
    Transplant Proc; 2009 Oct; 41(8):3347-52. PubMed ID: 19857747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
    Dieterlen MT; Bittner HB; Klein S; von Salisch S; Mittag A; Tárnok A; Dhein S; Mohr FW; Barten MJ
    Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.
    Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F
    Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
    Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
    Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro.
    Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J
    Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
    Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
    Flores MG; Zhang S; Ha A; Holm B; Reitz BA; Morris RE; Borie DC
    J Immunol Methods; 2004 Jun; 289(1-2):123-35. PubMed ID: 15251418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.